Anti‐TNF‐α‐induced psoriasis: Case report of an unusual adverse event
- 28 July 2006
- journal article
- Published by Wiley in International Journal of Dermatology
- Vol. 45 (8) , 982-983
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The tumour necrosis factor-alpha inhibitor adalimumab rapidly reverses the decrease in epidermal Langerhans cell density in psoriatic plaquesBritish Journal of Dermatology, 2005
- Psoriasis induced by anti–tumor necrosis factor therapy: A paradoxical adverse reactionArthritis & Rheumatism, 2005
- New therapies for rheumatoid arthritisClinical and Experimental Immunology, 2005
- Psoriatic arthritis treatment: biological response modifiersAnnals of the Rheumatic Diseases, 2005
- Successful treatment of psoriatic onycho‐pachydermo periostitis (POPP) with adalimumabArthritis & Rheumatism, 2005
- Skin reaction to adalimumabArthritis & Rheumatism, 2004
- Biology of tumor necrosis factor‐α– implications for psoriasisExperimental Dermatology, 2004
- Etanercept as Monotherapy in Patients with PsoriasisNew England Journal of Medicine, 2003
- Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trialThe Lancet, 2001